Earnings History Data for Chembio Diagnostics, Inc. (CEMI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Chembio Diagnostics, Inc.

CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-08-2021 AH 4:05 PM ET
(Aug 5)
CEMI Chembio Diagnostics, Inc. 71.44 -0.35 -0.38 -0.40 Chembio Diagnostics EPS misses by $0.04, misses on revenue
[8/5/2021 5:05 PM]
3.00 -0.52 
(-14.77%)
3.00 -0.52 
(-14.77%)
2.06 - 8.75 6,632,558 15,360,000 590,215
06-05-2021 AH 4:05 PM ET
(May 6)
CEMI Chembio Diagnostics, Inc. 74.07 -0.22 -0.30 -0.25 Chembio Diagnostics EPS beats by $0.10, beats on revenue
[5/6/2021 4:28 PM]
3.43 -0.07 
(-2.00%)
3.45 -0.05 
(-1.43%)
3.01 - 13.33 518,482 490,000 5,603
11-03-2021 AH 4:05 PM ET
(Mar 11)
CEMI Chembio Diagnostics, Inc. 96.04 -0.35 0.00 -0.23 Chembio Diagnostics EPS misses by $0.07, beats on revenue
[3/11/2021 4:21 PM]
4.32 -0.62 
(-12.65%)
4.40 -0.54 
(-10.93%)
2.25 - 15.89 1,045,229 836,542 36,846
05-11-2020 AH 4:05 PM ET
(Nov 5)
CEMI Chembio Diagnostics, Inc. 92.14 -0.28 -0.24 -0.22 Chembio Diagnostics EPS misses by $0.02, beats on revenue
[11/5/2020 5:16 PM]
4.74 0.30 
(6.88%)
4.76 0.33 
(7.45%)
2.25 - 15.89 1,111,903 1,170,694 47,333
06-08-2020 AH 4:05 PM ET
(Aug 6)
CEMI Chembio Diagnostics, Inc. 118.39 -0.40 -0.33 -0.19 Chembio Diagnostics EPS misses by $0.02, beats on revenue
[8/6/2020 4:53 PM]
5.30 -0.14 
(-2.57%)
4.90 -0.54 
(-9.93%)
2.25 - 15.89 3,175,444 5,560,557 430,425